Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilent Technologies Inc.
TRADE NEWS: Agilent Technologies Expands Therapeutic Nucleic Acids Manufacturing Capacity
May 23rd, 2008
Agilent Technologies Inc. (NYSE:A) announced the expansion of its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colo. Agilent's Nucleic Acids Solutions Division is adding large-scale nucleic acid synthesis, purification and drying capacity that will come on stream by the end of 2008. As a part of this expansion, Agilent has purchased from Dowpharma all of the assets of its Nucleic Acid Medicines business. The financial terms of the purchase were not disclosed. This is the second manufacturing expansion for the Boulder, Colo., facility since Agilent purchased the business in 2006. "This expansion represents a significant...
Source: Health Business Week (2008-05-23)
|
